Phreesia Inc.
American healthcare software company
PHR NYSE
ISIN US71944F1066 SEC CIK 1412408
Follow Phreesia
Weekly email: filings, results
Revenue, last quarter
$129.5M
+10.4% vs same quarter last year
Net income
$1.9M
+193.3% vs same quarter last year
EPS, diluted
$0.03
+200% vs same quarter last year
Operating cash flow
$18.3M
+23.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | $467.8M | $2.3M |
| FY25 | $410.5M | −$58.5M |
| FY24 | $346M | −$136.9M |
| FY23 | $280.9M | −$176.1M |
| FY22 | $213.2M | −$118.2M |
| FY21 | $148.7M | −$27.3M |
| FY20 | $124.8M | −$20.3M |
| FY19 | $99.9M | −$15.1M |
| FY18 | $79.8M | −$18.2M |
| FY17 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY26 | −1.4% | 0.5% |
| FY25 | −14.2% | −14.3% |
| FY24 | −39.4% | −39.6% |
| FY23 | −62.9% | −62.7% |
| FY22 | −54.8% | −55.4% |
| FY21 | −17.3% | −18.4% |
| FY20 | −12.3% | −16.3% |
| FY19 | −9.5% | −15.1% |
| FY18 | −18.2% | −22.8% |
| FY17 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY26 | $67.7M |
| FY25 | $23.7M |
| FY24 | −$38.2M |
| FY23 | −$94.9M |
| FY22 | −$93.1M |
| FY21 | −$8.4M |
| FY20 | −$6.2M |
| FY19 | −$6.9M |
| FY18 | −$17.7M |
| FY17 | - |
- Phreesia
- Industrials median
Show the numbers
| Year | Phreesia | Industrials median |
|---|---|---|
| FY26 | 0.5% | 1.9% |
| FY25 | −14.3% | 2.5% |
| FY24 | −39.6% | 3.3% |
| FY23 | −62.7% | 3.7% |
| FY22 | −55.4% | 3.8% |
| FY21 | −18.4% | 3.7% |
| FY20 | −16.3% | 0.3% |
| FY19 | −15.1% | 3.8% |
| FY18 | −22.8% | 3.9% |
| FY17 | - | 4% |